Journal for Veterinary Medicine, Biotechnology and Biosafety
Volume
12, Issue 1, February 2026, Pages 39–46
ISSN 2411-3174 (print version) ISSN 2411-0388
(online version)
TOXICOKINETICS
OF ZINC IN RATS AFTER A SINGLE ORAL ADMINISTRATION OF ZINC CARBONATE
NANOPARTICLES
Koshevoy V. I. 1,
Naumenko S. V. 1, Zhukova I. O. 1,
Bespalova I. I. 2, Yefimova S. L. 2
1 State
Biotechnological University, Kharkiv, Ukraine, e-mail: koshevoyvsevolod@gmail.com
2 Institute for
Scintillation Materials of the National Academy of Sciences of Ukraine,
Kharkiv, Ukraine
Download
PDF (print version)
Citation for print version: Koshevoy, V. I.,
Naumenko, S. V., Zhukova, I. O., Bespalova, I. I.
and Yefimova, S. L. (2026) ‘Toxicokinetics of zinc in rats
after a single oral administration of zinc carbonate nanoparticles’, Journal for Veterinary Medicine, Biotechnology and Biosafety, 12(1),
pp. 39–46.
Download
PDF (online version)
Citation for online version: Koshevoy, V. I.,
Naumenko, S. V., Zhukova, I. O., Bespalova, I. I.
and Yefimova, S. L. (2026) ‘Toxicokinetics of zinc in rats
after a single oral administration of zinc carbonate nanoparticles’, Journal for Veterinary Medicine, Biotechnology and Biosafety, 12(1),
pp. 39–46. DOI: 10.36016/JVMBBS-2026-12-1-5.
Summary. Creating modern feed
additives based on biologically active nanomaterials is an important area of
research for improving mineral metabolism in animals and poultry. A significant
amount of research focuses on developing zinc nanoparticles with a wide range
of pharmacological effects. However, most zinc nanocomposites are toxic, even
in low doses, and can accumulate in the body, leading to long-term adverse
effects. To address this issue, zinc carbonate nanoparticles stabilized with
polyvinylpyrrolidone were synthesized and found to be non-toxic. The study
aimed to advance preclinical research on the toxicokinetics of these
nanoparticles by conducting an acute toxicity experiment. To this end, 96 male
Wistar rats were administered a single oral dose of a colloidal zinc carbonate nanoparticle
solution at the following doses: 50 mg/kg b. w. (group I),
500 mg/kg b. w. (group II), and 5,000 mg/kg b. w.
(group III), based on the absolute mass of the drug. The toxicokinetic
profile of the studied nanoparticles showed typical dynamics of changes in zinc
content in the organs and tissues of rats — an increase in the level
of this microelement in the blood (only in experimental group III on the 1st day
after administration of nanoparticles by 17.5%), liver (on the 1st day
in experimental group II by 18.5% and in experimental group III by
52.1%; subsequently, changes were observed only after administration of the
maximum dose of the drug — on the 3rd day by 30.7%,
on the 7th and 14th days, there was a tendency to
increase) and kidneys (by 25.0% in experimental group II and by 36.2% in
experimental group III on the 1st day after administration
of nanoparticles, on the 3rd day in experimental group II
it was higher by 14.9% in experimental group III by 15.9%, on the 7th day
of the experiment, the zinc content remained higher than the control values by
13.4% in experimental group II and by 17.7% in experimental
group III). Regardless of the dose of administered nanoparticles, zinc did
not accumulate in the heart, muscles, or skin with hair. By day 14, the zinc
levels in all of the rats’ examined organs and tissues were similar to
those of the control group. No significant changes in zinc content were
observed in experimental group I throughout the experiment. Therefore,
zinc carbonate nanoparticles are safe regarding toxicokinetic parameters and do
not cause long-term accumulation
Keywords: toxicity, distribution,
organs, tissues
References:
Abdelhakeem, E.,
Mohamed, S. A., Beherei, H. H., Moaness, M. and
Hegazy, D. (2025) ‘Novel biocompatible hyaluronic acid (HA)/polyvinylpyrrolidone
(PVP) composites containing silver decorated-zinc MOF nanoparticles:
antimicrobial activity, drug delivery and wound healing’, AAPS
PharmSciTech, 27(1), p. 5. doi: 10.1208/s12249-025-03243-z.
Abo-El-Sooud, K., Abd-El
Hakim, Y. M., Hashem, M. M. M., El-Metwally, A. E.,
Hassan, B. A. and El-Nour, H. H. M. (2023)
‘Restorative effects of gallic acid against sub-chronic hepatic toxicity
of co-exposure to zinc oxide nanoparticles and arsenic trioxide in male
rats’, Heliyon, 9(6), p. e17326. doi: 10.1016/j.heliyon.2023.e17326.
Ali, A., Saeed, S.,
Hussain, R., Afzal, G., Siddique, A. B., Parveen, G.,
Hasan, M. and Caprioli, G. (2023) ‘Synthesis and
characterization of silica, silver-silica, and zinc oxide-silica nanoparticles
for evaluation of blood biochemistry, oxidative stress, and hepatotoxicity in
albino rats’, ACS Omega, 8(23), pp. 20900–20911. doi: 10.1021/acsomega.3c01674.
Ashraf, M., Zulfiqar, F.,
Ijaz, U., Rauf, U., Riaz, M., Arshad, S., Jamil Khan, M.
and Sahin, T. (2025) ‘Nanotechnology, nano-systems and applications
of nanoparticles in novel drug delivery — a comprehensive
review’, Pakistan Journal of Pharmaceutical Sciences, 38(2), pp. 669–677.
Available at: https://www.pjps.pk/uploads/2025/06/1749142227.pdf.
Baek, M., Chung, H. E.,
Yu, J., Lee, J. A., Kim, T. H., Oh, J. M., Lee, W. J.,
Paek, S. M., Lee, J. K., Jeong, J.,
Choy, J. H. and Choi, S. J. (2012) ‘Pharmacokinetics,
tissue distribution, and excretion of zinc oxide nanoparticles’, International
Journal of Nanomedicine, 7,
pp. 3081–3097. doi: 10.2147/IJN.S32593.
Bautista-Pérez, R.,
Cano-Martínez, A., Herrera-Rodríguez, M. A.,
Ramos-Godinez, M. D. P., Pérez Reyes, O. L.,
Chirino, Y. I., Rodríguez Serrano, Z. J. and
López-Marure, R. (2024) ‘Oral exposure to titanium dioxide
E171 and zinc oxide nanoparticles induces multi-organ damage in rats: role of
ceramide’, International Journal of Molecular Sciences, 25(11),
p. 5881. doi: 10.3390/ijms25115881.
Bayat, M., Daei, S.,
Ziamajidi, N., Abbasalipourkabir, R. and Nourian, A. (2023)
‘The protective effects of vitamins A, C, and E on zinc oxide
nanoparticles (ZnO NPs)-induced liver oxidative stress in male Wistar
rats’, Drug and Chemical Toxicology, 46(2), pp. 209–218. doi: 10.1080/01480545.2021.2016809.
Cao, F., Liang, K.,
Tang, W. W., Ni, Q. Y., Ji, Z. Y.,
Zha, C. K., Wang, Y. K., Jiang, Z. X.,
Hou, S., Tao, L. M. and Wang, X. (2024)
‘Polyvinylpyrrolidone-curcumin nanoparticles with immune regulatory and
metabolism regulatory effects for the treatment of experimental autoimmune
uveitis’, Journal of Controlled Release, 372,
pp. 551–570. doi: 10.1016/j.jconrel.2024.06.047.
CE (The Council of Europe). (1986) European Convention for the Protection of
Vertebrate Animals Used for Experimental and Other Scientific Purposes.
(European Treaty Series, No. 123). Strasbourg: The Council of Europe.
Available at: https://conventions.coe.int/treaty/en/treaties/html/123.htm.
CEC (The Council of the European Communities)
(2010) ‘Directive 2010/63/EU of the European Parliament and of the
Council of 22 September 2010 on the protection of animals used for
scientific purposes’, The Official
Journal of the European Communities, L 276, pp. 33–79.
Available at: http://data.europa.eu/eli/dir/2010/63/oj.
Chen, A., Feng, X., Sun, T.,
Zhang, Y., An, S. and Shao, L. (2016) ‘Evaluation of the
effect of time on the distribution of zinc oxide nanoparticles in tissues of
rats and mice: a systematic review’, IET Nanobiotechnology, 10(3),
pp. 97–106. doi: 10.1049/iet-nbt.2015.0006.
Cho, W. S., Kang, B. C.,
Lee, J. K., Jeong, J., Che, J. H. and Seok, S. H.
(2013) ‘Comparative absorption, distribution, and excretion of titanium
dioxide and zinc oxide nanoparticles after repeated oral administration’,
Particle and Fibre Toxicology, 10(1), p. 9. doi: 10.1186/1743-8977-10-9.
Choi, S.-J. and Choy, J.-H. (2014)
‘Biokinetics of zinc oxide nanoparticles: toxicokinetics, biological
fates, and protein interaction’, International Journal of Nanomedicine,
9(2), pp. 261–269. doi: 10.2147/ijn.s57920.
Ćurlin, M., Barbir, R., Dabelić, S.,
Ljubojević, M., Goessler, W., Micek, V.,
Žuntar, I., Pavić, M., Božičević, L.,
Pavičić, I. and Vinković Vrček, I. (2021)
‘Sex affects the response of Wistar rats to polyvinyl pyrrolidone
(PVP)-coated silver nanoparticles in an oral 28 days repeated dose
toxicity study’, Particle and Fibre Toxicology, 18(1), p. 38.
doi: 10.1186/s12989-021-00425-y.
Czyżowska, A. and Barbasz, A.
(2022) ‘A review: Zinc oxide nanoparticles — friends or
enemies?’, International Journal of Environmental Health Research,
32(4), pp. 1–17. doi: 10.1080/09603123.2020.1805415.
Deore, M. S., Keerthana, S.,
Naqvi, S., Kumar, A. and Flora, S. J. S. (2021)
‘Alpha-lipoic acid protects co-exposure to lead and zinc oxide
nanoparticles induced neuro, immuno and male reproductive toxicity in
rats’, Frontiers in Pharmacology, 12, p. 626238. doi: 10.3389/fphar.2021.626238.
Ding, X. Y., Hong, C. J.,
Liu, Y., Gu, Z. L., Xing, K. L., Zhu, A. J.,
Chen, W. L., Shi, L. S., Zhang, X. N. and
Zhang, Q. (2012) ‘Pharmacokinetics, tissue distribution, and
metabolites of a polyvinylpyrrolidone-coated norcantharidin chitosan
nanoparticle formulation in rats and mice, using LC-MS/MS’, International
Journal of Nanomedicine, 7,
pp. 1723–1735. doi: 10.2147/IJN.S29696.
Do Carmo Neto, J. R.,
Franco, P. I. R., Braga, Y. L. L.,
de Oliveira, J. F., Perini, H. F.,
Albuquerque, L. F. D., Martins, D. B.,
Helmo, F. R., Andrade, A. A., Miguel, M. P.,
Celes, M. R. N., Rocha, T. L.,
Almeida Silva, A. C., Machado, J. R. and da
Silva, M. V. (2024) ‘Toxicity assessment of new Ag-ZnO/AgO
nanocomposites: An in vitro and in vivo approach’, Journal of
Functional Biomaterials, 15(3), p. 51. doi: 10.3390/jfb15030051.
El-Saadony, M. T., Fang, G.,
Yan, S., Alkafaas, S. S., El Nasharty, M. A., Khedr, S. A.,
Hussien, A. M., Ghosh, S., Dladla, M.,
Elkafas, S. S., Ibrahim, E. H., Salem, H. M.,
Mosa, W. F., Ahmed, A. E., Mohammed, D. M., Korma, S. A.,
El-Tarabily, M. K., Saad, A. M.,
El-Tarabily, K. A. and AbuQamar, S. F. (2024) ‘Green
synthesis of zinc oxide nanoparticles: Preparation, characterization, and
biomedical applications — A review’, International Journal
of Nanomedicine, 19, pp. 12889–12937.
doi: 10.2147/IJN.S487188.
Fatima, A., Zaheer, T.,
Pal, K., Abbas, R. Z., Akhtar, T., Ali, S. and
Mahmood, M. S. (2024) ‘Zinc oxide nanoparticles significant
role in poultry and novel toxicological mechanisms’, Biological Trace
Element Research, 202(1),
pp. 268–290. doi: 10.1007/s12011-023-03651-x.
Fennell, T. R.,
Mortensen, N. P., Black, S. R., Snyder, R. W.,
Levine, K. E., Poitras, E., Harrington, J. M.,
Wingard, C. J., Holland, N. A., Pathmasiri, W. and
Sumner, S. C. (2017) ‘Disposition of intravenously or orally
administered silver nanoparticles in pregnant rats and the effect on the
biochemical profile in urine’, Journal of Applied Toxicology,
37(5), pp. 530–544. doi: 10.1002/jat.3387.
Ferdous, Z., Beegam, S.,
Tariq, S., Ali, B. H. and Nemmar, A. (2018) ‘The in vitro effect of polyvinylpyrrolidone
and citrate coated silver nanoparticles on erythrocytic oxidative damage and
eryptosis’, Cellular Physiology and Biochemistry, 49(4),
pp. 1577–1588. doi: 10.1159/000493460.
Fujihara, J. and Nishimoto, N.
(2024) ‘Review of zinc oxide nanoparticles: toxicokinetics, tissue
distribution for various exposure routes, toxicological effects, toxicity
mechanism in mammals, and an approach for toxicity reduction’, Biological
Trace Element Research, 202(1),
pp. 9–23. doi: 10.1007/s12011-023-03644-w.
Fujihara, J., Tongu, M.,
Hashimoto, H., Yamada, T., Kimura-Kataoka, K., Yasuda, T.,
Fujita, Y. and Takeshita, H. (2015) ‘Distribution and toxicity
evaluation of ZnO dispersion nanoparticles in single intravenously exposed
mice’, The Journal of Medical Investigation, 62(1‒2),
pp. 45–50. doi: 10.2152/jmi.62.45.
Hadrup, N., Vogel, U. and
Jacobsen, N. R. (2025) ‘Biokinetics of inhaled silver, gold,
copper oxide, and zinc oxide nanoparticles: A review’, Nanotoxicology,
19(3), pp. 259–289. doi: 10.1080/17435390.2025.2476994.
Hashim, M., Anjum, S.,
Mujahid, H., Alotaibi, K. S., Albattal, S. B.,
Ghamry, H. I. and Soliman, M. M. (2025) ‘Thymoquinone
loaded zinc oxide nanoformulations synthesis, characterization and evaluation
of their efficacy against carbon tetrachloride induced hepatorenal toxicity in
rats’, Toxicology Research, 14(2),
p. tfaf037. doi: 10.1093/toxres/tfaf037.
Iqbal, R., Qureshi, O. S.,
Yousaf, A. M., Raza, S. A., Sarwar, H. S., Shahnaz, G.,
Saleem, U. and Sohail, M. F. (2021) ‘Enhanced solubility
and biopharmaceutical performance of atorvastatin and metformin via electrospun
polyvinylpyrrolidone-hyaluronic acid composite nanoparticles’, European
Journal of Pharmaceutical Sciences, 161, p. 105817. doi: 10.1016/j.ejps.2021.105817.
Jafary, F., Motamedi, S. and
Karimi, I. (2023) ‘Veterinary nanomedicine: Pros and cons’, Veterinary
Medicine and Science, 9(1), pp. 494–506. doi: 10.1002/vms3.1050.
Kausar, S., Jabeen, F.,
Latif, M. A. and Asad, M. (2023) ‘Characterization, dose
dependent assessment of hepatorenal oxidative stress, hematological parameters
and histopathological divulging of the hepatic damages induced by Zinc Oxide
Nanoparticles (ZnO-NPs) in adult male Sprague dawley rats’, Saudi
Journal of Biological Sciences, 30(9), p. 103745. doi: 10.1016/j.sjbs.2023.103745.
Keerthana, S. and Kumar, A. (2020)
‘Potential risks and benefits of zinc oxide nanoparticles: A systematic
review’, Critical Reviews in Toxicology, 50(1),
pp. 47–71. doi: 10.1080/10408444.2020.1726282.
Kermanizadeh, A.,
Powell, L. G., Stone, V. and Møller, P. (2018)
‘Nanodelivery systems and stabilized solid-drug nanoparticles for orally
administered medicine: current landscape’, International Journal of
Nanomedicine, 13, pp. 7575–7605. doi: 10.2147/ijn.s177418.
Koshevoy, V., Naumenko, S.,
Orobchenko, O. and Bespalova, I. (2023) ‘Acute toxicity of zinc
carbonate nanocrystals on white mice model’ [Hostra toksychnist
nanokrystaliv tsynku karbonatu na modeli bilykh myshei], Scientific
Messenger of Lviv National University of Veterinary Medicine and
Biotechnologies named after S. Z. Gzhytskyj. Series: Veterinary
Sciences [Naukovyi visnyk Lvivskoho natsionalnoho universytetu veterynarnoi
medytsyny ta biotekhnolohii imeni S. Z. Gzhytskoho. Seriia:
Veterynarni Nauky], 25(112),
pp. 123–130. doi: 10.32718/nvlvet11220.
[in Ukrainian].
Koshevoy, V. I.,
Naumenko, S. V., Bespalova, I. I., Radzikhovskyi, M. L.
and Balym, Yu. P. (2024a) ‘Dynamics of the activity of
hepato-specific enzymes and the state of protein synthesizer function of the
liver in rats during chronic intake of zinc carbonate hydroxide
nanoparticles’ [Dynamika aktyvnosti hepatospetsyfichnykh enzymiv ta stan
proteinsyntezuvalnoi funktsii pechinky u shchuriv za khronichnoho
nadkhodzhennia nanochastynok tsynku hidrokarbonatu], Veterinary Medicine
[Veterynarna medytsyna], 110,
pp. 188–196. doi: 10.36016/VM-2024-110-29.
[in Ukrainian].
Koshevoy, V. I.,
Naumenko, S. V., Bespalova, I. I. and
Yefimova, S. L. (2024b) ‘Biochemical parameters of
nephrotoxicity of zinc hydrocarbonate nanocrystals’ [Biokhimichni
parametry nefrotoksychnosti nanokrystaliv tsynku hidrokarbonatu], Scientific
Messenger of Lviv National University of Veterinary Medicine and
Biotechnologies. Series: Veterinary Sciences [Naukovyi visnyk Lvivskoho
natsionalnoho universytetu veterynarnoi medytsyny ta biotekhnolohii. Seriia:
Veterynarni nauky], 26(116),
pp. 270–277. doi: 10.32718/nvlvet11639.
[in Ukrainian].
Koshevoy, V., Naumenko, S.,
Bespalova, I. and Yefimova, S. (2025a). ‘Effect of zinc
carbonate nanoparticles subchronic intake on antioxidant status of male
rabbits’, Journal for Veterinary Medicine Biotechnology and Biosafety,
11(4), pp. 3‒11. doi: 10.36016/jvmbbs-2025-11-4-1.
Koshevoy, V. I.,
Naumenko, S. V., Bespalova, I. I. and
Yefimova, S. L. (2025b) ‘Hematotoxicity of zinc carbonate
nanoparticles in the Wistar rat model’, Ukrainian Journal of
Veterinary and Agricultural Sciences,
8(1), pp. 21–26. doi: 10.32718/ujvas8-1.04.
Lee, J., Yu, W. J.,
Song, J., Sung, C., Jeong, E. J., Han, J. S.,
Kim, P., Jo, E., Eom, I., Kim, H. M.,
Kwon, J. T., Choi, K., Choi, J., Kim, H.,
Lee, H., Park, J., Jin, S. M. and Park, K. (2016)
‘Developmental toxicity of intravenously injected zinc oxide
nanoparticles in rats’, Archives of Pharmacal Research, 39(12),
pp. 1682–1692. doi: 10.1007/s12272-016-0767-z.
Li, M., Zou, P., Tyner, K. and
Lee, S. (2017) ‘Physiologically based pharmacokinetic (PBPK)
modeling of pharmaceutical nanoparticles’, The AAPS Journal,
19(1), pp. 26–42. doi: 10.1208/s12248-016-0010-3.
Li, W., Lu, X., Jiang, L. and
Wang, X. (2024a) ‘Biosafety and pharmacokinetic characteristics of
polyethylene pyrrolidone modified nano selenium in rats’, BMC
Biotechnology, 24(1), p. 98. doi: 10.1186/s12896-024-00915-9.
Li, W., Lu, X., Jiang, L. and
Wang, X. (2024b) ‘Radioprotective effect of polyvinylpyrrolidone
modified selenium nanoparticles and its antioxidation mechanism in vitro and in vivo’, Frontiers in Bioengineering and Biotechnology,
12, p. 1392339. doi: 10.3389/fbioe.2024.1392339.
Li, Y., Li, J., Li, M.,
Sun, J., Shang, X. and Ma, Y. (2024a) ‘Biological
mechanism of ZnO nanomaterials’, Journal of Applied Toxicology, 44(1), pp. 107–117. doi: 10.1002/jat.4522.
Li, Y., Lu, Y., Li, J.,
Li, M., Gou, H., Sun, X., Xu, X., Song, B.,
Li, Z. and Ma, Y. (2024b) ‘Screening of low-toxic zinc oxide
nanomaterials and study the apoptosis mechanism of NSC-34 cells’, Biotechnology
Journal, 19(2),
p. e2300443. doi: 10.1002/biot.202300443.
Liang, C., Fang, J., Hu, J.,
Geng, X., Liu, H., Feng, Y., Wang, W., Cui, W.,
Yu, Z. and Jia, X. (2022) ‘Toxicokinetics of zinc oxide
nanoparticles and food grade bulk-sized zinc oxide in rats after oral
dosages’, NanoImpact, 25,
p. 100368. doi: 10.1016/j.impact.2021.100368.
Liu, J., Feng, X., Wei, L.,
Chen, L., Song, B. and Shao, L. (2016) ‘The toxicology of
ion-shedding zinc oxide nanoparticles’, Critical Reviews in
Toxicology, 46(4),
pp. 348–384. doi: 10.3109/10408444.2015.1137864.
Malik, S., Muhammad, K. and
Waheed, Y. (2023) ‘Emerging applications of nanotechnology in
healthcare and medicine’, Molecules, 28(18), p. 6624. doi: 10.3390/molecules28186624.
Naumenko, S., Koshevoy, V., Matsenko, O.,
Miroshnikova, O., Zhukova, I. and Bespalova, I. (2023)
‘Antioxidant properties and toxic risks of using metal nanoparticles on
health and productivity in poultry’, Journal of World`s Poultry
Research, 13(3),
pp. 292–306. doi: 10.36380/jwpr.2023.32.
Paek, H. J., Lee, Y. J.,
Chung, H. E., Yoo, N. H., Lee, J. A.,
Kim, M. K., Lee, J. K., Jeong, J. and
Choi, S. J. (2013) ‘Modulation of the pharmacokinetics of zinc
oxide nanoparticles and their fates in
vivo’, Nanoscale, 5(23),
pp. 11416–11427. doi: 10.1039/c3nr02140h.
Park, E. J., Jeong, U.,
Yoon, C. and Kim, Y. (2017) ‘Comparison of distribution and
toxicity of different types of zinc-based nanoparticles’, Environmental
Toxicology, 32(4),
pp. 1363–1374. doi: 10.1002/tox.22330.
Pei, X., Jiang, H., Xu, G.,
Li, C., Li, D. and Tang, S. (2022) ‘Lethality of zinc
oxide nanoparticles surpasses conventional zinc oxide via oxidative stress,
mitochondrial damage and calcium overload: A comparative hepatotoxicity
study’, International Journal of Molecular Sciences, 23(12), p. 6724. doi: 10.3390/ijms23126724.
Rahman, H. S.,
Othman, H. H., Abdullah, R., Edin, H. A. S. and
Al-Haj, N. A. (2022) ‘Beneficial and toxicological aspects of
zinc oxide nanoparticles in animals’, Veterinary Medicine and Science, 8(4), pp. 1769–1779.
doi: 10.1002/vms3.814.
Rehman, N., Jabeen, F.,
Asad, M., Nijabat, A., Ali, A., Khan, S. U.,
Luna-Arias, J. P., Mashwani, Z. U., Siddiqa, A.,
Karthikeyan, A. and Ahmad, A. (2024) ‘Exposure to zinc oxide
nanoparticles induced reproductive toxicities in male Sprague Dawley
rats’, Journal of Trace Elements in Medicine and Biology, 83, p. 127411. doi: 10.1016/j.jtemb.2024.127411.
Sarcinelli, M. A.,
Gullo, M. P., Gentile, G., Cocca, M. C., Errico, M. E.,
Avella, M. and Tavares, M. I. B. (2021)
‘Polyvinylpyrrolidone/ Montmorillonite/ Zinc oxide bionanosystems
prepared by spray drying’, Journal of Nanoscience and Nanotechnology,
21(9), pp. 4830–4839. doi: 10.1166/jnn.2021.19284.
Shahrousvand, M.,
Mirmasoudi, S. S., Pourmohammadi-Bejarpasi, Z.,
Feizkhah, A., Mobayen, M., Hedayati, M., Sadeghi, M.,
Esmaelzadeh, M., Mirkatoul, F. B. and Jamshidi, S. (2023)
‘Polyacrylic acid/ polyvinylpyrrolidone hydrogel wound dressing
containing zinc oxide nanoparticles promote wound healing in a rat model of
excision injury’, Heliyon, 9(8),
p. e19230. doi: 10.1016/j.heliyon.2023.e19230.
Simmonds, R. C. (2017)
‘Chapter 4. Bioethics and animal use in programs of research,
teaching, and testing’, in Weichbrod, R. H.,
Thompson, G. A. and Norton, J. N. (eds.) Management of
Animal Care and Use Programs in Research, Education, and Testing. 2nd ed.
Boca Raton: CRC Press, pp. 35–62. doi: 10.1201/9781315152189-4.
Van Emden, H. F. (2019) Statistics for Terrified Biologists. 2nd ed.
Hoboken, NJ: John Wiley & Sons. ISBN 9781119563679.
VRU (Verkhovna Rada Ukrainy) (2006) ‘Law
of Ukraine No. 3447-IV of 21.02.2006 ‘About protection of animals
from cruel treatment’ [Zakon Ukrainy № 3447-IV vid 21.02.2006
‘Pro zakhyst tvaryn vid zhorstokoho povodzhennia’], News of the
Verkhovna Rada of Ukraine [Vidomosti Verkhovnoi Rady Ukrainy], 27,
art. 230. Available at: https://zakon.rada.gov.ua/laws/3447-15.
[in Ukrainian].
Wang, C., Lu, J., Zhou, L.,
Li, J., Xu, J., Li, W., Zhang, L., Zhong, X. and
Wang, T. (2016) ‘Effects of long-term exposure to zinc oxide
nanoparticles on development, zinc metabolism and biodistribution of minerals
(Zn, Fe, Cu, Mn) in mice’, PloS One, 11(10), p. e0164434. doi: 10.1371/journal.pone.0164434.
Yang, J., Xiong, D. and
Long, M. (2025) ‘Zinc oxide nanoparticles as next-generation feed
additives: bridging antimicrobial efficacy, growth promotion, and sustainable
strategies in animal nutrition’, Nanomaterials, 15(13), p. 1030. doi: 10.3390/nano15131030.
Yang, K., Zhu, R., Bao, H.,
Xu, S., Gao, Y., Xue, Y., Wang, J., Wang, X.,
Pan, Y., Hong, L. and Zhao, K. (2025) ‘Chitosan-based
nanomaterials: Pioneering a review in veterinary medicine applications’, International
Journal of Biological Macromolecules, 320(4), p. 146011. doi: 10.1016/j.ijbiomac.2025.146011.
Yue, W., Wang, X., Zhang, J.,
Bao, J. and Yao, M. (2024) ‘Construction of immobilized laccase
system based on ZnO and degradation of mesotrione’, Toxics, 12(6), p. 434. doi: 10.3390/toxics12060434.
Yun, J. W., Yoon, J. H.,
Kang, B. C., Cho, N. H., Seok, S. H.,
Min, S. K., Min, J. H., Che, J. H. and
Kim, Y. K. (2015) ‘The toxicity and distribution of iron oxide-zinc
oxide core-shell nanoparticles in C57BL/6 mice after repeated subcutaneous
administration’, Journal of Applied Toxicology, 35(6), pp. 593–602. doi: 10.1002/jat.3102.
Zhang, S. Q., Yu, X. F.,
Zhang, H. B., Peng, N., Chen, Z. X., Cheng, Q.,
Zhang, X. L., Cheng, S. H. and Zhang, Y. (2018)
‘Comparison of the oral absorption, distribution, excretion, and
bioavailability of zinc sulfate, zinc gluconate, and zinc-enriched yeast in
rats’, Molecular Nutrition
& Food Research, 62(7), p. e1700981. doi: 10.1002/mnfr.201700981.
